Brokerages Set Progyny, Inc. (NASDAQ:PGNY) PT at $23.64

Progyny, Inc. (NASDAQ:PGNY) has earned an average recommendation of “Hold” from the thirteen brokerages that are presently covering the company, Marketbeat reports. Eight investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $23.64.

PGNY has been the topic of several research reports. JPMorgan Chase & Co. upped their target price on Progyny from $17.00 to $23.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 28th. Bank of America raised their price target on shares of Progyny from $21.00 to $25.00 and gave the company a “buy” rating in a report on Tuesday, February 11th. BTIG Research raised shares of Progyny from a “neutral” rating to a “buy” rating and set a $28.00 target price on the stock in a research report on Monday, March 31st. Finally, Canaccord Genuity Group raised their price objective on Progyny from $17.00 to $23.00 and gave the company a “hold” rating in a research note on Friday, February 28th.

Progyny Stock Down 1.9 %

Shares of NASDAQ:PGNY opened at $21.40 on Monday. The company has a market cap of $1.83 billion, a P/E ratio of 36.90, a price-to-earnings-growth ratio of 2.39 and a beta of 1.33. The company’s fifty day moving average is $21.98 and its two-hundred day moving average is $18.77. Progyny has a 12-month low of $13.39 and a 12-month high of $33.84.

Institutional Investors Weigh In On Progyny

A number of institutional investors have recently added to or reduced their stakes in PGNY. Signaturefd LLC lifted its position in shares of Progyny by 1,355.0% in the 4th quarter. Signaturefd LLC now owns 1,455 shares of the company’s stock worth $25,000 after acquiring an additional 1,355 shares during the period. GAMMA Investing LLC raised its stake in shares of Progyny by 341.4% in the fourth quarter. GAMMA Investing LLC now owns 1,611 shares of the company’s stock valued at $28,000 after purchasing an additional 1,246 shares in the last quarter. Nisa Investment Advisors LLC lifted its position in Progyny by 108.4% in the fourth quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company’s stock worth $51,000 after purchasing an additional 1,526 shares during the period. Caitlin John LLC boosted its stake in Progyny by 2,974.8% during the fourth quarter. Caitlin John LLC now owns 3,290 shares of the company’s stock worth $57,000 after buying an additional 3,183 shares in the last quarter. Finally, Natixis acquired a new position in shares of Progyny in the 4th quarter valued at $69,000. 94.93% of the stock is owned by institutional investors and hedge funds.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.